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Abstract
Background: Rumen microbes metabolize 22:6n-3. However, pathways of 22:6n-3 biohydrogenation and ruminal
microbes involved in this process are not known. In this study, we examine the ability of the well-known rumen
biohydrogenating bacteria, Butyrivibrio fibrisolvens D1 and Butyrivibrio proteoclasticus P18, to hydrogenate 22:6n-3.
Results: Butyrivibrio fibrisolvens D1 failed to hydrogenate 22:6n-3 (0.5 to 32 μg/mL) in growth medium containing
autoclaved ruminal fluid that either had or had not been centrifuged. Growth of B. fibrisolvens was delayed at the
higher 22:6n-3 concentrations; however, total volatile fatty acid production was not affected. Butyrivibrio
proteoclasticus P18 hydrogenated 22:6n-3 in growth medium containing autoclaved ruminal fluid that either had or
had not been centrifuged. Biohydrogenation only started when volatile fatty acid production or growth of B.
proteoclasticus P18 had been initiated, which might suggest that growth or metabolic activity is a prerequisite for
the metabolism of 22:6n-3. The amount of 22:6n-3 hydrogenated was quantitatively recovered in several
intermediate products eluting on the gas chromatogram between 22:6n-3 and 22:0. Formation of neither 22:0 nor
22:6 conjugated fatty acids was observed during 22:6n-3 metabolism. Extensive metabolism was observed at lower
initial concentrations of 22:6n-3 (5, 10 and 20 μg/mL) whereas increasing concentrations of 22:6n-3 (40 and
80 μg/mL) inhibited its metabolism. Stearic acid formation (18:0) from 18:2n-6 by B. proteoclasticus P18 was
retarded, but not completely inhibited, in the presence of 22:6n-3 and this effect was dependent on 22:6n-3
concentration.
Conclusions: For the first time, our study identified ruminal bacteria with the ability to hydrogenate 22:6n-3. The
gradual appearance of intermediates indicates that biohydrogenation of 22:6n-3 by B. proteoclasticus P18 occurs by
pathways of isomerization and hydrogenation resulting in a variety of unsaturated 22 carbon fatty acids. During the
simultaneous presence of 18:2n-6 and 22:6n-3, B. proteoclasticus P18 initiated 22:6n-3 metabolism before converting
18:1 isomers into 18:0.
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Background
Docosahexaenoic acid (22:6n-3) is a poly-unsaturated fatty
acid (PUFA) that has been associated with physiological
benefits in many species, including human and dairy cows.
The amount of 22:6n-3 available for absorption in the
small intestine can be increased by intake of marine prod-
ucts (e.g. fish oil, marine algae). However, this is not
straightforward in ruminants as extensive biohydrogena-
tion in the rumen leaves little 22:6n-3 for absorption.
Biohydrogenation of PUFA is one of the important mi-
crobial processes in the rumen that has a major influ-
ence on FA composition of meat and milk. It is well
documented that ruminal bacteria are responsible for
most of the biohydrogenation process in the rumen [1],
and it is thought to be a detoxification mechanism as
PUFA are more toxic than saturated FA [2]. Metabolism
of linoleic (18:2n-6) and linolenic (18:3n-3) acids is well
studied in vivo and in vitro and involves an initial isom-
erization step to yield a FA with a conjugated double
bond (a pair of double bonds separated by one single
bond). In vitro studies with mixed and pure rumen bac-
teria helped to construct the detailed biohydrogenation
pathways of 18:2n-6 and 18:3n-3, and the identification
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of bacterial species involved in this process [3–5]. How-
ever, information on the biohydrogenation of 22:6n-3 is
still lacking. Several reports show extensive metabolism
of 22:6n-3 in vivo [6, 7] and in vitro with mixed rumen
cultures [8, 9]. However, none of the studies identified
bacterial species responsible for its metabolism. Maia
et al. [10] investigated PUFA metabolism of 26 predom-
inant rumen bacterial species and found none of them
able to metabolize 22:6n-3. Sakurama et al. [11] screened
about 100 strains of anaerobic bacteria including some
ruminal bacteria and found none of them metabolized
22:6n-3. Pure culture studies focusing on the main
rumen hydrogenating bacteria, Butyrivibrio fibrisolvens
and Butyrivibrio proteoclasticus also failed to success-
fully induce 22:6n-3 hydrogenation [10].
The aim of this study was to examine the metabolism
of 22:6n-3 by the known biohydrogenating ruminal bac-
teria, B. fibrisolvens and B. proteoclasticus. To our know-
ledge, in previous experiments these bacterial species
have been exposed to a single concentration of 22:6n-3
(50 μg/mL) which may be toxic for them [10]. We used
lower concentrations of 22:6n-3 in our experiments.
Additionally, we modified the standard Butyrivibrio
growth medium in an attempt to promote biohydro-
genation. Experiments 1–5 were conducted using the
growth medium containing autoclaved-uncentrifuged
rumen fluid and experiments 6−8 were conducted using
the growth medium containing autoclaved-centrifuged
rumen fluid (Table 1).
Results
22:6n-3 metabolism by B. fibrisolvens D1
Both autoclaved-centrifuged and -uncentrifuged rumen
fluid (Exp. 1 and 6), did not result in 22:6n-3 metabolism
at any concentration. The effect of various concentra-
tions of 22:6n-3 on growth, fermentation and biohydro-
genation ability of B. fibrisolvens D1 (Exp. 6) in media
containing 20 % (v/v) autoclaved-centrifuged rumen
fluid are summarized in Table 2. No growth was ob-
served till 48 h with the highest concentration of 22:6n-
3 (32 μg/mL), whereas a considerably shorter lag phase
(4 h) was observed with the same concentration of
18:2n-6 in the same medium. Optical density (OD600)
measured at stationary phase was lower (P < 0.05) at the
concentration of 16 μg/mL compared to the lower con-
centrations (0 and 8 μg/mL). Total volatile fatty acid
(VFA) production and VFA profile were not affected
(P > 0.05) by the 22:6n-3 concentrations. The main fer-
mentation products included butyrate and small
amounts of acetate (about 96 % and 4 % of molar con-
centration of VFA respectively).
22:6n-3 metabolism by B. proteoclasticus P18
In the growth medium containing 50 % (v/v) autoclaved-
uncentrifuged rumen fluid, B. proteoclasticus P18 hydro-
genated 22:6n-3 (Exp. 2). At the concentrations of 20 μg/
mL (0.2 mg/tube), most of the 22:6n-3 was metabolized,
leaving little residual 22:6n-3 (0.005 ± 0.003 mg/tube) after
48 h of incubation. The type of headspace gas had no
influence on the residual amount of 22:6n-3. Total VFA
production and VFA profile were not affected (P > 0.05) by
different gas phases (data not shown). The main fermenta-
tion products included butyrate and acetate (about 70 %
and 30 % of molar concentration of VFA respectively).
Effect of length of incubation period on 22:6n-3
metabolism by B. proteoclasticus P18
The extent of 22:6n-3 metabolism in media containing
50 % (v/v) autoclaved-uncentrifuged rumen fluid at dif-
ferent time points (Exp. 3) is shown in Fig. 1 along with
the VFA production at the respective time points. Me-
tabolism of 22:6n-3 (20 μg/mL) initiated after 4 h and
80 % of 22:6n-3 was hydrogenated between 4 h and 12 h
of incubation. Accumulation of VFA initiated prior to
Table 1 Overview of the in vitro experiments conducted in this study
Exp. Autoclaved-rumen fluid/tube (%) Bacteriaa 22:6n-3 (μg/mL) Gas phaseb Incubation period (h)
Uncentrifuged
1 20 and 50 B. fibri 20 CO2 0 and 48
2 50 B. proteo 20 CO2, H2 and N2 0 and 48
3 50 B. proteo 20 H2 0, 2, 4, 8, 12, 24 and 48
4 50 B. proteo 5, 10, 40 and 80 H2 0 and 48
5c 50 B. proteo 10 and 40 H2 0, 2, 4, 8, 12, 24 and 48
Centrifuged
6 20 and 50 B. fibri 0.5, 1, 2, 4, 8, 16 and 32 CO2 0 and 48
7 20 B. proteo 20 H2 0 and 24
8 20 B. proteo 20 H2 0, 2, 4, 8, 12 and 24
aBacteria used in the experiment -B. fibri: Butyrivibrio fibrisolvens D1; B. proteo: Butyrivibrio proteoclasticus P18
bheadspace gas phase
cThe growth medium used in experiment 5 contained 40 μg/mL of 18:2n-6
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the start of 22:6n-3 metabolism and 93 % of VFA were
produced within the first 12 h of the incubation. Both
the rate of 22:6n-3 disappearance and VFA production
slowed down after 12 h of incubation. Significant VFA
production was not observed after 12 h, whereas hydrogen-
ation of 22:6n-3 slowly continued. As a result, the amount
of 22:6n-3 recovered after 48 h was lower (P < 0.05) than
the amount recovered after 12 and 24 h of incubation.
Detailed analysis of chromatograms did not provide
evidence of 22:0 formations during metabolism of 22:6n-
3. Peaks appearance at different time points did not
show accumulation of conjugated 22:6 products. The in-
termediates produced during the 48 h incubation com-
prised about 12 different FA (Table 3) and characteristic
ion fragments are presented in Table 4. During the early
hours of incubation (<8 h), 4 new peaks (i.e. peaks which
were not present in the 0 h incubation) appeared (Fig. 2a:
peaks 1-4). Of these, peak 3 was the most abundant and
the molecular ion at m/z = 383 and the loss of the ter-
minal methyl group (m/z = 368) confirmed the docosa-
pentaenoic acid structure. The odd numbered ion
fragment at m/z = 153 is an indication for the location of
a Δ5 double bond [12]. Gaps of 12 amu between m/z =
208 and 220; 248 and 260; 288 and 300 and between 328
and 340 confirmed the location of ethylenic double
bonds in position Δ10, Δ13, Δ16 and Δ19 (Table 4). Peak
1 showed the same retention time as 22:5n-3 present in
the FAME standard and ion fragments at 168 and 180,
208 and 220, 248 and 260, 288 and 300, and 328 and
340 allowed us to identify this peak as 22:5n-3 [13]. A
final docosapentaenoic acid (peak 2) was identified as
Δ4, Δ10, Δ13, Δ16, Δ19-22:5 based on the molecular ion
at m/z = 383, gaps of 12 amu between m/z = 208 and
220; 248 and 260; 288 and 300 and between 328 and 340
and the double bond in position 4 is defined by the fin-
gerprint ion at m/z = 139 and 152 [14]. One docosate-
traenoic acid was identified as Δ10, Δ13, Δ16, Δ19-22:4
(peak 4) based on the molecular ion at m/z = 385 and
gaps of 12 amu between m/z = 210 and 222; 250 and
262; 290 and 302 and between 330 and 342. During the
further incubation, the abundance of these peaks grad-
ually decreased and were accompanied with the appear-
ance of four 22:3 FA (peaks 5-8: Fig. 2a) and four 22:2
FA (peaks 9-12: Fig. 2a). Peaks 5 and 7 showed a similar
mass spectra and were identified as Δ13, Δ16, Δ20-22:3.
Ion fragments separated by 12 amu gaps located the
double bonds at Δ13, Δ16 and Δ20 with a prominent
ion at m/z 332 confirming the presence of allylic bonds
at Δ16 and Δ20. Peak 6 showed the same retention time
as 22:3n-3 present in the FAME standard and double
Table 2 Effects of different concentrations of 22:6n-3 on
growth, VFA production and biohydrogenation by Butyrivibrio
fibrisolvens D1
Concentration of 22:6n-3 (μg/mL)
0 8 16 32
Lag phase (h) < 3 < 3 4-5 > 48
OD600
c 1.13 ± 0.07a 1.22 ± 0.10a 1.04 ± 0.07b NDd
Total VFA (μmol/tube) 93.0 ± 3.3 94.0 ± 6.2 94.2 ± 4.9 ND
Biohydrogenation No No No No
cIncrease in OD600 after 48 h of incubation compared to initial OD600 at 0 h
dND- Not determined as growth was not started till 48 h
Means with different superscripts in OD600 (a and b) are significantly
different (P < 0.05)
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Fig. 1 Metabolism of 22:6n-3 and VFA accumulation at different time points by Butyrivibrio proteoclasticus P18. Growth medium included 50 %
(v/v) of autoclaved-uncentrifuged rumen fluid. Hydrogen was used as the headspace gas. ● Residual 22:6n-3 in the tube and▲ VFA accumulated.
Results are means and SD from 2 biological replicates, each of which had 2 analytical replicates. For residual 22:6n-3 and accumulated VFA, data
points with different letters are significantly different (P < 0.05)
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bond positions were confirmed by ion fragments sepa-
rated by 12 amu gaps (Table 4). Peak 8 was identified as
Δ11, Δ16, Δ19-22:3 based on ion fragments at 224 and
236, 292 and 304, and 332 and 344. Peaks 9 and 11
showed a similar mass spectra and were identified as
Δ16, Δ20-22:2. Ion fragments separated by 12 amu gaps
located the double bonds at Δ16 and Δ20 (Table 4) with
a prominent ion at m/z 334 confirming the presence of
allylic bonds at Δ16 and Δ20. Peak 10 was Δ16, Δ19-22:2
(ion fragments separated by 12 amu gaps at 294 and
306, and 334 and 346) and the prominent ion at m/z
306 combined ion fragments separated by 12 amu gaps
at 266 and 278, and 320 and 332 allowed us to identify
peak 12 as Δ14, Δ18-22:2.
In experiments conducted in media containing
autoclaved-centrifuged rumen fluid (20 % v/v), B. proteo-
clasticus hydrogenated 22:6n-3 at the concentration of
20 μg/mL (Exp. 7 and 8). After 24 h of incubation, little
Table 3 Amount of metabolized 22:6n-3 (μg/tube) recovered in FAME peaks. Incubation was performed in growth medium
containing autoclaved-uncentrifuged rumen fluid (50 % v/v) in the presence of 22:6n-3 (20 μg/mL) with Butyrivibrio proteoclasticus
P18. Tubes were withdrawn at 0, 2, 4, 8, 12, 24 and 48 h incubation to study the extent of 22:6n-3 biohydrogenation. Peak numbers
correspond to peaks in Fig. 2
Peaks Incubation duration (h)
4 8 12 24 48
1 Δ7, Δ10, Δ13, Δ16, Δ19-22:5 2.18 ± 0.66 16.88 ± 0.94 16.38 ± 2.09 3.39 ± 1.71 2.93 ± 1.04
2 Δ4, Δ10, Δ13, Δ16, Δ19-22:5 - 3.36 ± 0.38 4.19 ± 1.04 1.07 ± 0.34 0.43 ± 0.58
3 Δ5, Δ10, Δ13, Δ16, Δ19-22:5 3.92 ± 1.29 44.38 ± 1.59 16.60 ± 5.80 7.40 ± 3.51 3.68 ± 2.42
4 Δ10, Δ13, Δ16, Δ19-22:4 9.42 ± 2.55 55.40 ± 3.00 11.27 ± 2.34 19.69 ± 2.41
5 Δ13, Δ16, Δ20-22:3 3.12 ± 0.70 8.17 ± 1.99 1.73 ± 0.11 3.63 ± 1.62
6 Δ13, Δ16, Δ19-22:3 - 9.91 ± 1.90 33.05 ± 4.66 36.02 ± 5.88
7 Δ13, Δ16, Δ20-22:3 - 0.69 ± 0.86 4.91 ± 0.38 7.24 ± 0.49
8 Δ11, Δ16, Δ19-22:3 - 9.10 ± 0.99 10.69 ± 1.66 8.77 ± 1.22
9 Δ16, Δ20-22:2 - 0.72 ± 0.90 7.45 ± 0.49 10.75 ± 0.76
10 Δ16, Δ19-22:2 - 6.31 ± 1.67 31.24 ± 2.96 37.31 ± 4.61
11 Δ16, Δ20-22:2 - 1.34 ± 0.93 11.75 ± 1.25 16.69 ± 1.46
12 Δ14, Δ18-22:2 - - 5.03 ± 0.48 7.49 ± 0.56
Table 4 Characteristic ion fragments recorded during gas-chromatography mass-spectrometry analysis of 4,4-dimethyloxazoline
derivatives of newly formed fatty acids during biohydrogenation of 22:6n-3 by Butyrivirbio proteoclasticus. Peak numbers correspond
to peaks in Fig. 2
Peak Fatty acid Characteristic ion fragments (m/z, relative intensity)
1 Δ7, Δ10, Δ13, Δ16, Δ19-22:5 113 (64), 126 (100), 168 (9), 180 (24), 194 (21), 208 (11), 220 (6), 234 (12), 248 (16), 260 (6), 274 (12), 288 (6), 300
(5), 314 (10), 328 (3), 340 (2), 354 (2), 368 (4), 383 (9)
2 Δ4, Δ10, Δ13, Δ16, Δ19-22:5 113 (100), 126 (17), 139 (15), 152 (49), 166 (52), 180 (15), 194 (25), 208 (4), 220 (5), 234 (14), 248 (6), 260 (7), 274
(1), 288 (8), 300 (4), 314 (12), 328 (3), 340 (2), 354 (4), 368 (4), 383 (11)
3 Δ5, Δ10, Δ13, Δ16, Δ19-22:5 113 (100), 126 (21), 153 (18), 166 (4), 180 (14), 194 (9), 208 (1), 220 (3), 234 (8), 248 (2), 260 (1), 274 (3), 288 (2),
300 (1), 314 (4), 328 (1), 340 (1), 354 (1), 368 (2), 383 (3)
4 Δ10, Δ13, Δ16, Δ19-22:4 113 (88), 126 (100), 168 (11), 182 (10), 196 (13), 210 (5), 222 (4), 236 (6), 250 (13), 262 (4), 276 (12), 290 (24),
302 (8), 316 (25), 330 (8), 342 (5), 356 (6), 370 (8), 385 (28)
5/7 Δ13, Δ16, Δ20-22:3 113 (64), 126 (57), 168 (9), 182 (6), 196 (4), 210 (4), 224 (4), 238 (7), 252 (3), 264 (1), 278 (8), 292 (7), 304 (3),
318 (3), 332 (100), 346 (2), 358 (3), 372 (8), 387 (17)
6 Δ13, Δ16, Δ19-22:3 113 (100), 126 (100), 168 (14), 182 (11), 196 (8), 210 (7), 224 (7), 238 (10), 252 (4), 264 (2), 278 (7), 292 (12),
304 (5), 318 (22), 332 (16), 344 (8), 358 (13), 372 (15), 387 (42)
8 Δ11, Δ16, Δ19-22:3 113 (80), 126 (100), 168 (18), 182 (11), 196 (9), 210 (11), 224 (7), 236 (4), 250 (3), 264 (9), 278 (45), 292 (2), 304
(5), 318 (14), 332 (6), 344 (5), 358 (3), 372 (15), 387 (21)
9/11 Δ16, Δ20-22:2 113 (100), 126 (56), 168 (11), 182 (7), 196 (4), 210 (3), 224 (3), 238 (6), 252 (3), 266 (4), 280 (10), 294 (8), 306 (1),
320 (2), 334 (75), 348 (2), 360 (2), 374 (6), 389 (11)
10 Δ16, Δ19-22:2 113 (100), 126 (69), 168 (12), 182 (8), 196 (5), 210 (4), 224 (6), 238 (8), 252 (5), 266 (6), 280 (10), 294 (3), 306 (2),
320 (13), 334 (11), 346 (9), 360 (10), 374 (19), 389 (34)
12 Δ14, Δ18-22:2 113 (100), 126 (83), 168 (14), 182 (15), 196 (9), 210 (6), 224 (7), 238 (13), 252 (7), 266 (7), 278 (3), 292 (14), 306
1(80), 320 (<1), 332 (5), 346 (12), 360 (25), 374 (14), 389 (26)
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residual 22:6n-3 was left in the tube (0.006 ± 0.0003 mg/
tube). Figure 3 shows the kinetics of 22:6n-3 disappear-
ance along with OD600 measured at the respective time
points (Exp. 8). Metabolism of 22:6n-3 initiated after 4 h
and 93 % of 22:6n-3 was hydrogenated between 4 h and
12 h of incubation. Growth of B. proteoclasticus (mea-
sured as the increase in the OD600) initiated prior to the
start of 22:6n-3 metabolism and exponentially increased
between 4 h and 12 h. The products formed during the
biohydrogenation of 22:6n-3 (Table 5) were identical as
those described before (Exp. 3).
Effect of initial concentration of 22:6n-3 on 22:6n-3
metabolism by B. proteoclasticus P18
The initial concentration of 22:6n-3 influenced the extent
of its metabolism. Extensive metabolism of 22:6n-3 was
observed at lower concentrations (5, 10 and 20 μg/mL).
Addition of 5, 10 and 20 μg/ml 22:6n-3 resulted in the ac-
cumulation of 22:2 and 22:3 FA and represented > 80 % of
22:6n-3 that was metabolized during the 48 h incubation
(Table 6). This implies that the initial 22:5 and 22:4 FA
were further hydrogenated. An increase in the initial con-
centration of 22:6n-3 increased the amount of 22:6n-3
metabolized during 48 h incubation period, but only up to
a concentration of about 40 μg/mL (Fig. 4). Although in
absolute amounts, more 22:6n-3 disappeared at higher
22:6n-3 concentrations, analysis of the chromatograms
showed that extensive biohydrogenation of intermediate
products was inhibited (Table 6 and Fig. 2b). At the initial
concentration of 40 μg/mL, the residual 22:6n-3 retrieved
from the tubes after 48 h incubation was 9 % of the initial
amount. Under this condition, 65 % of the metabolized
22:6n-3 accumulated as a single compound identified as
Δ10, Δ13, Δ16, Δ19-22:4. Further conversion of this prod-
uct seemed to be inhibited. When the initial 22:6n-3
concentration was increased to 80 μg/mL, the residual
22:6n-3 retrieved from the tubes after 48 h of incubation
was 45 % of the initial amount and > 90 % of the
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Fig. 2 Partial chromatogram with peaks representing fatty acids from 22:0 to 22:6n-3. These chromatograms obtained from (a) 0, 8, 12 and 24 h
incubations with 22:6n-3 (20 μg/mL) and (b) 48 h incubations with 22:6n-3 (20, 40 and 80 μg/mL). In both cases Butyrivibrio proteoclasticus P18
had grown in the media containing 50 % (v/v) autoclaved- uncentrifuged rumen fluid. Peaks visible at 0 h represent the fatty acids present in the
rumen fluid and peaks numbers (1–12) represent new peaks formed during the 22:6n-3 metabolism
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metabolized 22:6n-3 accumulated as 22:4 and 22:5 FA.
Subsequent biohydrogenation of these products seemed
completely inhibited at this concentration.
Total VFA production was not affected by the ini-
tial concentration of 22:6n-3 except for the highest
concentration (80 μg/mL). At the highest initial con-
centration (80 μg/mL) VFA production after 48 h was
higher (P < 0.05) compared to the lower concentra-
tions (16.4 ± 0.5 and 15.1 ± 0.5 μmol/mL respectively),
but the VFA profile was not affected (P > 0.05).
Effect of presence of 22:6n-3 on 18:2n-6 metabolism by B.
proteoclasticus P18
Table 7 shows the conjugated linoleic acids (CLA), vac-
cenic acid (VA; trans-11-18:1) and stearic acid (SA;18:0)
formation from 40 μg/mL 18:2n-6 in presence of 0 (con-
trol), low (10 μg/mL) and high (40 μg/mL) 22:6n-3,
along with VFA formation and residual 22:6n-3. The for-
mation of CLA was observed as soon as inoculation was
made. Although formation of CLA and VA were not af-
fected (P > 0.05), conversion of VA into SA (18:0) was
Table 5 Amount of metabolized 22:6n-3 (μg/tube) recovered in FAME peaks. Incubation was performed in growth medium
containing autoclaved-centrifuged rumen fluid (20 % v/v) in the presence of 22:6n-3 (20 μg/mL) with Butyrivibrio proteoclasticus
P18. Tubes were withdrawn at 0, 2, 4, 8, 12 and 24 h incubation to study the extent of 22:6n-3 biohydrogenation. Peak numbers
correspond to peaks in Fig. 2
Peaks Incubation duration (h)
4 8 12 24
1 Δ7, Δ10, Δ13, Δ16, Δ19-22:5 5.51 ± 0.59 19.55 ± 2.82 13.72 ± 3.93 -
2 Δ4, Δ10, Δ13, Δ16, Δ19-22:5 - 3.68 ± 1.22 5.21 ± 3.88 -
3 Δ5, Δ10, Δ13, Δ16, Δ19-22:5 4.41 ± 1.10 53.32 ± 8.58 28.37 ± 39.9 -
4 Δ10, Δ13, Δ16, Δ19-22:4 11.34 ± 3.05 91.90 ± 40.6 26.41 ± 36.1
5 Δ13, Δ16, Δ20-22:3 6.89 ± 1.25 11.86 ± 3.27 9.34 ± 5.26
6 Δ13, Δ16, Δ19-22:3 - 10.26 ± 5.80 38.69 ± 3.97
7 Δ13, Δ16, Δ20-22:3 - 0.36 ± 0.32 6.75 ± 5.59
8 Δ11, Δ16, Δ19-22:3 - 10.10 ± 6.52 15.73 ± 16.6
9 Δ16, Δ20-22:2 - 0.34 ± 0.30 7.36 ± 7.36
10 Δ16, Δ19-22:2 - 1.38 ± 1.21 26.68 ± 11.4
11 Δ16, Δ20-22:2 - - 10.09 ± 10.8
12 Δ14, Δ18-22:2 - - 6.69 ± 5.96
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Fig. 3 Metabolism of 22:6n-3 and optical density measurements at different time points by Butyrivibrio proteoclasticus P18. Growth medium
included 20 % (v/v) of autoclaved-centrifuged rumen fluid. Hydrogen was used as the headspace gas. ● Residual 22:6n-3 in the tube ♦ Optical
density (OD600) measured at respective time points. Results are means and SD from 3 replicates. For residual 22:6n-3 and OD600 measured, data
points with different letters are significantly different (P < 0.05)
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retarded (P > 0.05) in the presence of 22:6n-3 and this ef-
fect was dependent on 22:6n-3 concentration. Volatile
fatty acids production was not initiated until all the
18:2n-6 had been metabolized and converted into VA re-
gardless of presence of high or low 22:6n-3. Both 18:0
formation and 22:6n-3 metabolism began after the initi-
ation of VFA production. In the control tubes, 18:0 for-
mation started at about 4 h as soon as VFA production
began and this conversion was rapid thereafter (Table 7).
In the presence of low 22:6n-3 (10 μg/mL), B. proteo-
clasticus P18 initiated 22:6n-3 metabolism around 4 h,
ahead of 18:0 formation (around 8 h of incubation). As a
result, a small lag phase was observed in 18:0 formation
after the initiation of VFA production. In presence of
high 22:6n-3 (40 μg/mL), 18:0 formation was delayed to
12 h and this conversion was slower thereafter.
Discussion
Butyrivibrio species are a genetically and functionally di-
verse group of bacteria present in gastrointestinal sys-
tems [4, 15]. Based on the mechanism of butyrate
formation, this group can be classified into two sub-
groups: vaccenic acid-producing (low butyrate kinase ac-
tivity) and stearic acid-producing (high butyrate kinase
activity). Accordingly, B. fibrisolvens and B. proteoclasti-
cus are belonging to the vaccenic acid-producing and
Table 6 Amount of metabolized 22:6n-3 (μg/tube) recovered in FAME peaks. Incubation was performed in growth medium
containing autoclaved-uncentrifuged rumen fluid (50 % v/v) in the presence of 22:6n-3 (5, 10, 20, 40 and 80 μg/mL) with Butyrivibrio
proteoclasticus P18. Tubes were withdrawn at 48 h of incubation to study the extent of 22:6n-3 biohydrogenation. Peak numbers
correspond to peaks in Fig. 2
Initial concentration of 22:6n-3 (μg/tube)
Peaks 50 100 200 400 800
1 Δ7, Δ10, Δ13, Δ16, Δ19-22:5 0.63 ± 0.75 1.15 ± 0.28 2.93 ± 1.04 25.14 ± 3.03 77.118 ± 1.30
2 Δ4, Δ10, Δ13, Δ16, Δ19-22:5 - - 0.43 ± 0.58 5.08 ± 1.05 21.42 ± 0.69
3 Δ5, Δ10, Δ13, Δ16, Δ19-22:5 0.87 ± 1.13 1.11 ± 0.96 3.68 ± 2.42 29.16 ± 3.92 177.29 ± 5.04
4 Δ10, Δ13, Δ16, Δ19-22:4 5.26 ± 1.98 8.14 ± 2.11 19.69 ± 2.41 208.41 ± 14.7 78.81 ± 7.61
5 Δ13, Δ16, Δ20-22:3 0.41 ± 0.82 1.17 ± 0.82 3.63 ± 1.62 15.80 ± 2.34 12.05 ± 1.17
6 Δ13, Δ16, Δ19-22:3 5.82 ± 0.77 14.26 ± 0.62 36.02 ± 5.88 22.22 ± 3.63 3.48 ± 1.19
7 Δ13, Δ16, Δ20-22:3 2.84 ± 0.46 5.02 ± 0.20 7.24 ± 0.49 - -
8 Δ11, Δ16, Δ19-22:3 2.33 ± 0.86 4.26 ± 0.66 8.77 ± 1.22 26.98 ± 3.47 5.61 ± 0.81
9 Δ16, Δ20-22:2 4.14 ± 0.53 7.14 ± 0.39 10.75 ± 0.76 - -
10 Δ16, Δ19-22:2 7.81 ± 0.81 15.92 ± 0.87 37.31 ± 4.61 5.53 ± 1.24 3.09 ± 1.05
11 Δ16, Δ20-22:2 8.83 ± 0.63 12.94 ± 0.59 16.69 ± 1.46 - -
12 Δ14, Δ18-22:2 3.34 ± 0.65 5.09 ± 0.35 7.49 ± 0.56 - -
0
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Fig. 4 Effect of initial concentration of 22:6n-3 (5 - 80 μg/mL) on its metabolism by Butyrivibrio proteoclasticus P18. Incubations were performed in
growth medium containing 50 % (v/v) of autoclaved-uncentrifuged rumen fluid for 48 h
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stearic acid-producing groups respectively [16]. Butyrivi-
brio fibrisolvens D1 and B. proteoclasticus P18 were
chosen for this study as a representative from each
group. However, the type species B. fibrisolvens D1
showed high butyrate kinase activity which is atypical to
the majority of B. fibrisolvens isolates [17].
Previous studies carried out with B. fibrisolvens and B.
proteoclasticus in M2 medium failed to show hydrogen-
ation of 22:6n-3 [2, 10]. The reason for this is probably
the high concentration of 22:6n-3 used in these studies
(50 μg/mL) which may have affected the growth of the
bacteria. Wallace et al. [4] showed growth to be a pre-
requisite for B. proteoclasticus P18 in order to form ste-
aric acid (18:0) from 18:2n-6. If this is also true for
22:6n-3 biohydrogenation, failure to grow when 22:6n-3
is present in previous experiments [2, 10] possibly ex-
plains the absence of 22:6n-3 biohydrogenation. To re-
duce the inhibitory effect of 22:6n-3 on growth, the
concentration of 22:6n-3 in the medium can be lowered
or substances which lower the toxicity of 22:6n-3 should
be included in the medium. Harfoot et al. [18] showed
that biohydrogenation was stimulated by rumen fluid
particles, enabling FA biohydrogenation by ruminal
bacteria. Experiments performed in our lab also showed
addition of autoclaved-uncentrifuged rumen fluid stimu-
lated the biohydrogenation of 22:6n-3 in mixed cultures
of rumen bacteria (Escobar M, Vlaeminck B and Fievez
V, unpublished results). Hence, we used autoclaved-
uncentrifuged rumen fluid to prepare the growth
medium. Additionally we used a lower concentration of
22:6n-3 than the concentration reported previously
(50 μg/mL) [2, 10].
Butyrivibrio fibrisolvens grew at low concentrations of
22:6n-3 without metabolizing it. Maia et al. [2] showed
that growth of B. fibrisolvens JW11 was not initiated
until all 18:2n-6 was metabolized and converted to VA,
such phenomenon was not observed with 22:6n-3. The
failure of B. fibrisolvens D1 to metabolize 22:6n-3 in the
current experiment might indicate they do not possess
the necessary enzymes for 22:6n-3 biohydrogenation.
However, further studies are warranted as B. fibrisolvens
D1 is atypical to other B. fibrisolvens in general.
In contrast with previous reports [10], we found B.
proteoclasticus P18 is able to hydrogenate 22:6n-3. To
our knowledge, this is the first report demonstrating
22:6n-3 biohydrogenation by a pure bacterial species.
Table 7 Linoleic acid metabolism (mg/tube) in presence of 22:6n-3 by B. proteoclasticus P18. Incubation was performed in growth
medium containing 40 μg/mL (0.4 mg/tube) of 18:2n-6 in presence of 0, 10 μg/mL (Low: 0.1 mg/tube) and 40 μg/mL (High: 0.4 mg/
tube) 22:6n-3. Growth medium included 50 % (v/v) of autoclaved-uncentrifuged rumen fluid and H2 gas was the headspace gas.
Value-presented in this table included the fatty acids and VFA of autoclaved-uncentrifuged rumen fluid used to prepare the growth
medium
Incubation duration (h)
22:6n-3 0 2 4 8 12 24 48
18:2n-6 0 0.27 ± 0.006a 0.09 ± 0.014b 0.08 ± 0.009bc 0.08 ± 0.002bc 0.09 ± 0.012b 0.06 ± 0.001c 0.05 ± 0.002c
(mg/tube) Low 0.25 ± 0.007a 0.09 ± 0.001bc 0.09 ± 0.002bc 0.09 ± 0.001bc 0.10 ± 0.003b 0.07 ± 0.006c 0.06 ± 0.002c
High 0.28 ± 0.099a 0.11 ± 0.002b 0.10 ± 0.011bc 0.10 ± 0.004b 0.10 ± 0.006b 0.07 ± 0.006c 0.06 ± 0.005c
CLA 0 0.07 ± 0.005a 0.02 ± 0.007b 0.00b 0.00b 0.00b 0.00b 0.00b
(mg/tube) Low 0.10 ± 0.007a* 0.02 ± 0.004b 0.00b 0.00b 0.00b 0.00b 0.00b
High 0.11 ± 0.073a 0.02 ± 0.003b 0.00b 0.00b 0.00b 0.00b 0.00b
VA 0 0.05 ± 0.005a 0.27 ± 0.026b 0.21 ± 0.011c 0.07 ± 0.003d 0.06 ± 0.005d 0.06 ± 0.003d 0.04 ± 0.008a
(mg/tube) Low 0.05 ± 0.005a 0.30 ± 0.010b* 0.29 ± 0.015c* 0.10 ± 0.007d* 0.07 ± 0.003e 0.07 ± 0.004e 0.07 ± 0.004e*
High 0.05 ± 0.026a 0.29 ± 0.005b* 0.28 ± 0.005b* 0.19 ± 0.005c** 0.11 ± 0.008d* 0.13 ± 0.010d* 0.10 ± 0.002d**
18:0 0 0.50 ± 0.011a 0.51 ± 0.041a 0.58 ± 0.014b 0.74 ± 0.056c 0.73 ± 0.020c 0.71 ± 0.016c 0.73 ± 0.019c
(mg/tube) Low 0.53 ± 0.019a 0.53 ± 0.009a 0.53 ± 0.022a* 0.67 ± 0.019b* 0.69 ± 0.018bc* 0.72 ± 0.010c 0.73 ± 0.010c
High 0.53 ± 0.006a 0.53 ± 0.003a 0.52 ± 0.017a* 0.54 ± 0.015a** 0.58 ± 0.015b** 0.65 ± 0.017c* 0.68 ± 0.007c*
VFA 0 434.1 ± 4.79a 436.4 ± 7.77a 469.6 ± 16.80b 541.7 ± 12.61c 545.7 ± 8.57c 585.2 ± 30.61d 567.6 ± 15.93d
(μmol/tube) Low 434.0 ± 9.61a 437.7 ± 6.01a 460.6 ± 3.09b 527.9 ± 6.54cd 542.9 ± 4.34de 557.0 ± 7.23e* 551.4 ± 5.35e
High 449.1 ± 16.6a 433.0 ± 8.91a 468.5 ± 21.71b 531.8 ± 8.25c 549.7 ± 6.14cd 562.1 ± 17.97d* 559.4 ± 2.82d
22:6n-3 Low 0.07 ± 0.005a 0.07 ± 0.002a 0.06 ± 0.002b 0.02 ± 0.001c 0.02 ± 0.001c 0.02 ± 0.003c 0.01 ± 0.000d
(mg/tube) High 0.31 ± 0.018a 0.30 ± 0.012a 0.29 ± 0.011a 0.17 ± 0.002b 0.11 ± 0.004c 0.09 ± 0.012c 0.06 ± 0.006d
CLA conjugated linoleic acid, VA vaccenic acid, VFA volatile fatty acids
For each fatty acids, subscript * represents different (P < 0.05) compared to 0 mg/tube 22:6n-3 and ** represents different (P < 0.05) compared to 0 and
0.1 mg/tube 22:6n-3 at the respective time point
Within each row means with different superscripts (a-e) are significantly different (P < 0.05)
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Temporal changes in 22:6n-3, VFA and OD600 during
the course of the incubation might indicate B. proteo-
clasticus must be growing to biohydrogenate 22:6n-3,
with little transformation occurring during the stationary
phase. Such observations were also made when demon-
strating the capability of B. proteoclasticus P18 to form
18:0 from 18:2n-6 [4]. Stationary-phase bacteria were
reported to be much less active in hydrogenation of
18:2n-6 than growing cells [4, 19]. This was explained by
a limited supply of reducing equivalents once the energy
sources in the medium had been depleted [4] as the con-
version of CLA to VA is NADH-dependent [20]. It
seems probable that a similar mechanism explains the
variation in rate of disappearance of 22:6n-3 during the
course of the incubation period. It is however not clear
whether growth or activity per se is needed for biohy-
drogenation, or that the association of disappearance of
22:6n-3, VFA and OD600 is merely a reflection of
changes in the culture closely associated with growth
and activity (e.g. biomass production, redox potential).
The metabolism of 22:6n-3 resulted in the appearance
of numerous compounds eluting during GC analysis be-
tween 22:0 and 22:6n-3. It has been speculated before
that ruminal hydrogenation of 22:6n-3 yields intermedi-
ates with 5 or 6 double bonds, containing at least one
trans double bond [1]. The position of the double bonds
in the most abundant 22:5 isomer (Δ5, Δ10, Δ13, Δ16,
Δ19-22:5) suggest the formation of this intermediate in-
volves izomerisation of the cis-4 double bond and reduc-
tion of the cis-7 double bond [21]. Initial izomerisation
of the cis-4 double bond of 22:6n-3 would result in the
formation of a conjugated product (Δ5, Δ7, Δ10, Δ13,
Δ16, Δ19-22:6). However, in the present series of experi-
ments, no accumulation of products eluting in the GC
chromatogram with a retention time greater than 22:6n-
3 was observed, a region where conjugated isomers of
22:6 would be expected to elute with the polar column
used in the present study. The lack of accumulation of a
conjugated FA might indicate they are transient prod-
ucts which did not accumulate at the time of sampling.
Alternatively, this might also indicate the initial product
of 22:6n-3 metabolism is not a conjugated FA. The accu-
mulation of 22:5 isomers produced during the initial
stages of 22:6n-3 biohydrogenation was transient, when
the initial 22:6n-3 concentration was low, and these iso-
mers were subsequently hydrogenated to more saturated
22:4, 22:3 and 22:2 isomers. The existence of two iso-
mers with identical double bond position (peak 5 and 7
as Δ13, Δ16, Δ20-22:3 and peak 9 and 11 as Δ16, Δ20-
22:2) indicates double bonds in the trans configuration
must be present. It is unclear to what extent the in-
creases in polyenoic trans fatty acids may offset some of
the expected benefits from the enrichment of 22:6n-3 in
ruminant derived foods [21].
Butyrivibrio proteoclasticus is the only known ruminal
bacterium with the capacity to biohydrogenate 18-
carbon FA to 18:0. Previous incubations with rumen
fluid have established that 22:6n-3 inhibits the complete
hydrogenation of 18-carbon unsaturated FA causing
trans 18:1 isomers to accumulate [8]. This is thought to
be related to the toxic effects of 22:6n-3 on the growth
and metabolic activity of B. proteoclasticus [22]. How-
ever, in vivo studies have failed to show the relationship
between 18:0 flow to the duodenum and B. proteoclasti-
cus DNA [7, 23]. Based on the findings of present study
we suggest that B. proteoclasticus probably starts to hy-
drogenate 22:6n-3 before converting 18:1 isomers to
18:0. Biohydrogenation is required to lower toxicity and
therefore the reduction of products containing more
double bonds are a greater priority which explains the
lack of 18:1 reduction at time points where biohydro-
genation of 22:6n-3 did occur. These findings possibly
explain the lack of relationship of duodenal 18:0 to the
duodenum and B. proteoclasticus DNA [7, 23].
Conclusions
Butyrivibrio proteoclasticus P18 is able to hydrogenate
22:6n-3 in vitro. The rate and extent of biohydrogena-
tion depended on the initial concentration of 22:6n-3
and the duration of incubation. Several 22:5, 22:4, 22:3
and 22:2 isomers were identified. The products formed
irrespective of the initial concentrations of 22:6n-3 and
type of growth media suggests B. proteoclasticus P18
had a consistent pathway of 22:6n-3 hydrogenation. Dur-
ing the simultaneous presence of both 18:2n-6 and
22:6n-3, B. proteoclasticus P18 initiated 22:6n-3 metabol-
ism before converting 18:1 isomers into 18:0. Under the
current culture conditions, B. fibrisolvens D1 failed to
hydrogenate 22:6n-3.
Methods
Microorganisms and cultivation
Butyrivibrio fibrisolvens D1 (DSM 3071) and B. proteo-
clasticus P18 were selected for this study. Butyrivibrio
fibrisolvens D1 was purchased from DSMZ (Deutsche
Sammlung von Mikroorganismen und Zellkulturen
GmbH, Braunschweig, Germany) and B. proteoclasticus
P18 was obtained from the culture collection of the
Rowett Institute of Nutrition and Health (University of
Aberdeen, Bucksburn, Aberdeen AB21 9SB, UK). Butyri-
vibrio medium (DSMZ: medium 704) was slightly modi-
fied: VFA mixture, haemin and glycerol were omitted
from the basic medium and L-cysteine-HCl was used as
the only reducing agent (0.5 g/l). The preparation
method of rumen fluid and the rumen fluid/buffer ratio
were also modified (Table 1).
Autoclaved-uncentrifuged or -centrifuged rumen fluids
were used for the growth media preparation. Rumen
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fluid was collected from 3 mature wethers, fitted with a
ruminal cannula, fed grass hay and a commercial grain
concentrate twice a day according to their maintenance
requirements. To obtain the centrifuged rumen fluid,
rumen fluid collected from cannulated wethers, was fil-
tered through a sieve with a pore size of 1 mm and then
fine particles were removed from the filtrate by centrifu-
gation at 10,000 g for 20 min at 4 °C. The supernatant
was sterilized by autoclaving for 20 min at 121 °C and
stored frozen at −20 °C. The stored rumen fluid was
thawed before use and any new precipitates formed were
removed by centrifugation at 12,000 g for 15 min at 4 °C.
For autoclaved-uncentrifuged rumen fluid, rumen fluid
collected from cannulated wethers was filtered through
a sieve with a pore size of 1 mm and autoclaved (20 min
at 121 °C), and used without further processing.
In vitro incubations were carried out anaerobically at
39 °C under continuous shaking in Hungate-type tubes
(16 mm dia., 125 mm long; Bellco Glass, Vineland, NJ,
USA) containing 9.5 ml of medium and closed with
screw caps fitted with butyl rubber septa (Chemglass
Life Sciences, Vineland, NJ, USA), and autoclaved for
20 min at 121 °C. Inoculum volumes were 5 % (v/v) of a
fresh culture that was grown in medium 704 for 12 h
(OD600 ≈ 1.7). Growth was determined by measuring the
culture density at 600 nm (Ultraspec10, Amersham Bio-
sciences corp., Piscataway, NJ, USA). At the end of the
experiment the incubations were stopped by placing the
tubes in ice water. pH was measured (Hanna instru-
ments, Temse, Belgium) and culture contents were sam-
pled for VFA and long chain FA (LCFA) analysis.
Fatty acid solution
Fatty acid solutions were prepared by dispersing 200 mg
of 22:6n-3 (Nu-check-Prep., Elysian, MN, USA) in
3.33 mL of a 0.06 M Tween-80 (Sigma Aldrich, St Louis,
MO) solution. Then 0.25 mL of 3 M NaOH was added
to obtain a clear solution. This solution was diluted with
distilled water to achieve a final 22:6n-3 concentration
of 10 mg/mL. The amount of Tween-80 and NaOH in
all the tubes was kept the same by using a blank solution
(prepared with Tween-80 and NaOH only). The required
amount of the FA solution was added before autoclaving
individually to each Hungate tube.
In vitro experiments
Previous experiments performed with Butyrivibrio spe-
cies in the medium containing centrifuged rumen fluid
failed to hydrogenate 22:6n-3 [2, 10]. As such, experi-
ments 1–5 (Table 1) were conducted using the growth
medium containing autoclaved-uncentrifuged rumen
fluid. In experiment 1, B. fibrisolvens was grown in the
medium containing either 20 or 50 % (v/v) autoclaved-
uncentrifuged rumen fluid. The concentration of 22:6n-3
used (20 μg/mL) was lower than the previously reported
value (50 μg/mL) [2, 10]. All treatments were conducted
with 3 replicates.
Since we saw the 22:6n-3 disappearance by B. proteo-
clasticus in the medium containing 50 % (v/v)
autoclaved-uncentrifuged rumen fluid, additional experi-
ments were conducted in this medium (Table 1). Influ-
ence of headspace gas (Exp. 2), incubation period (Exp.
3) and initial concentration of 22:6n-3 (Exp. 4) were
studied in these experiments. Butyrivibrio proteoclasticus
is the only stearic acid forming rumen bacteria so far
identified. Formation of stearic acid (18:0) may be af-
fected in the presence of 22:6n-3 as 22-C FA are more
toxic than the 18-C FA. As such influence of 18:2n-6
(40 μg/mL) on biohydrogenation of 22:6n-3 (0, 10 and
40 μg/mL) was studied in experiment 5. All treatments
were performed in duplicate (analytical replicates) with
inoculum from two different culture tubes (biological
replicates).
Experiments 6–8 were conducted using autoclaved-
centrifuged rumen fluid (Table 1). In experiment 6, B.
fibrisolvens was grown with different concentrations of
22:6n-3 and growth (culture density) was monitored
during the experiment. Lag time for the growth was de-
termined based on the time point at which the increase
in OD600 initiated. Linoleic acid (18:2n-6) was used as
the positive control. Treatments were performed in du-
plicate (analytical replicates) with inoculum from three
different culture tubes (biological replicates).
In experiment 7, we saw the disappearance of 22:6n-3
(20 μg/mL) by B. proteoclasticus in the medium contain-
ing 20 % (v/v) autoclaved-centrifuged rumen fluid after
24 h incubation. Kinetics of this disappearance was stud-
ied in experiment 8 along with the growth of the bac-
teria by measuring increase in culture density (OD600) at
the time of tube withdrawal. Three analytical replicates
were used for each treatment.
Analysis and calculation
For VFA analysis, 2 mL of incubation medium were col-
lected and acidified with 200 μL of formic acid which
contained the internal standard (10 mg of 2-ethyl butyric
acid/mL formic acid). After 15 min centrifugation at 4 °
C and 22,000 g, supernatant was filtered and an aliquot
was transferred into a 1.5 mL glass vial. Samples were
stored at 4 °C until VFA analysis using gas chromatog-
raphy (HP 7890A, Agilent Technologies, Diegem,
Belgium) equipped with a FID detector and a Supelco
Nukol capillary column (30 m × 0.25 mm × 0.25 μm,
Sigma-Aldrich, Diegem, Belgium). The temperature pro-
gram was as follows: 120 °C at injection for 0.2 min; in-
creased at 10 °C/min until 180 °C and remained at this
temperature for 3 min; injector temperature: 250 °C; de-
tector temperature 255 °C. For this temperature
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program, 0.3 μL was injected with a split/splitless ratio
of 25:1 using H2 as carrier gas at 0.8 mL/min. VFA peaks
were identified based on their retention times, compared
to external standards (Sigma Aldrich, St Louis, MO).
The remainder of the content in the Hungate tubes
after removal of 2 mL for VFA analysis (8 mL/tube) was
freeze-dried for LCFA analysis and FA were methylated
as described by Vlaeminck et al. [9]. Analysis of the FA
methyl esters (FAME) was carried out using a gas chro-
matograph (HP7890A, Agilent Technologies, Diegem,
Belgium) using a SP-2560 column (75 m x 0.18 mm, i.d. x
0.14 μm thickness, Supelco Analytical, Bellefonte, USA)
and a flame ionization detector. The temperature program
was initially 70 °C for 2 min, increasing at 15 °C/min to
150 °C, followed by a second increase at 1 °C/min up to
165 °C and holding for 12 min, followed by a third in-
crease at 5 °C/min to 210 °C, held at 210 °C for 20 min, in-
creased at 5 °C/min to 220 °C and held at 220 °C for
15 min. Inlet and detector temperatures were 250 and
255 °C, respectively. The split ratio was 50:1. Hydrogen
was used as the carrier gas at a flow rate of 1 mL/min.
Identities of peaks were determined using mixtures of
methyl ester standards (GLC463, Nu-Check-Prep., Inc.,
Elysian, MN, USA).
Quantification of FA was based on the area of the in-
ternal standard and on the conversion of peak areas to
the weight of FA by a theoretical response factor for
each FA [24, 25].
Structural analysis of fatty acid intermediates
Methyl esters not contained in commercially available
standards were identified based on GC-MS analysis of
DMOX derivatives prepared from FAME. Prior to prep-
aration of DMOX derivatives, FAME were fractionated
using Ag+-SPE columns (750 mg/6 mL, Supelco, Belle-
fonte, PA, USA). Columns were activated with 4 mL
acetone, followed by 4 mL hexane. The FAME of se-
lected samples, dissolved in 1 mL hexane, were loaded
on the column and eluted with hexane containing in-
creasing amounts of acetone (v/v): 6 mL (99/1), 2 ×
3 mL (96/4), 2 × 3 mL (90/10), 2 × 3 mL (0/100). This
was followed by elution with acetone containing increas-
ing amounts of acetonitrile (v/v): 2 × 3 mL (98/2), 2 ×
3 mL (96/4), 2 × 3 mL (94/6), 2 × 3 mL (90/10) and 2 ×
3 mL (80/20). All fractions were taken to dryness in a
stream of N2, dissolved in hexane and used for analysis
of FAME by GC, as described above, and preparation of
4, 4-dimethyloxazoline (DMOX) derivatives.
DMOX derivatives of FA were prepared by using a modi-
fied procedure [26]. Briefly, FAMEs were converted into
DMOX derivatives with 500 μL 2-amino-2-methyl-1-pro-
panol under a nitrogen atmosphere at 170 °C overnight.
DMOX derivatives were extracted twice with diethyl ether/
n-hexane (1:1, v/v) and sodium chloride-saturated water.
The organic layer was dried with anhydrous sodium
sulphate for 1 h, followed by evaporation until dry under
nitrogen. The DMOX derivatives were dissolved in hexane.
Identification of the DMOX derivatives of the biohy-
drogenation intermediates was based on electron impact
ionisation spectra obtained by gas chromatography-mass
spectrometry (GC-MS), using a gas chromatograph
(Trace2D-GC, Thermo Electron Corporation, Waltham,
MA, USA) coupled to a quadrupole mass detector
(DSQII, Thermo Electron Corporation) under an ionisa-
tion voltage of 70 eV, using helium as carrier gas. The
ion source and interface temperatures were maintained
at 200 °C and 250 °C, respectively. The column was a
SLB 5 ms capillary column (60 m x 0.25 mm, i.d. x
0.25 μm thickness, Supelco Analytical, Bellefonte, USA).
The electron impact ionization spectra obtained were
used to locate double bonds based on atomic mass unit
(amu) distances with an interval of 12 amu between the
most intense peaks of clusters of ions containing n and
n-1 carbon atoms, being interpreted as cleavage of the
double bond between carbon n and n + 1 in the fatty
acid moiety.
Statistical analysis
All statistical analysis was performed using SAS version
9.4 (SAS Institute Inc., Cary, NC). A least squares mean
ANOVA in the GLM procedure using 22:6n-3 level
(Exp. 1, 4, 5 and 6) or incubation time (Exp. 3 and 8) or
headspace gas (Exp. 2) as factors was used to test time
and treatment effects. The Tukey-Kramer test was per-
formed to assess which treatments differed in case of mul-
tiple (> 2) treatments. The differences among means with
P < 0.05 were considered to be statistically significant.
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